Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model
Related Posts
Grant JK, Jha K, Marrero N, Razavi AC, Boakye E, Anchouche K, Dzaye O, Budoff MJ, Shah S, Czarny MJ, Rotter JI, Guo X, Yao[...]
Abbasi A, Hansen N, Palade J, Paredes D, Meechoovet B, Van Keuren-Jensen K, Pirrotte P, Stringer WW. Serum extracellular vesicle RNA profiles in long COVID:[...]
Gami A, Zou S, Dardari ZA, Dudum R, Mok Y, Budoff MJ, Lutsey PL, Howard CM, Couper D, Matsushita K, Blaha MJ. Predictors of diffuse[...]